Infusion of autologous bone marrow mononuclear cells leads to transient reduction in proteinuria in treatment refractory patients with Idiopathic membranous nephropathy

BACKGROUND: The current treatment options for idiopathic membranous nephropathy (IMN) carry significant toxicity. In this prospective, observational pilot study, we used single time infusion of bone marrow derived autologous mononuclear cells (MNCs) in adult patients with treatment refractory IMN. M...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:BMC Nephrol
Hlavní autoři: Sengupta, Upal, Kumar, Vinod, Yadav, Ashok K, Marwaha, Neelam, Kohli, Harbir S, Sakhuja, Vinay, Jha, Vivekanand
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2013
Témata:
Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4219434/
https://ncbi.nlm.nih.gov/pubmed/24289828
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2369-14-262
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky